Perimenopause symptoms in Australia
A clinician's guide.
Clinician reviewed · June 2026
Most Australian women learn about perimenopause the same way: through a year or two of feeling like a slightly different person, with no one able to explain why. The federal government's National Menopause and Perimenopause Awareness Campaign, launched in 2025, exists precisely because that gap has been the norm for decades. This guide is written to close part of it. What is actually happening hormonally, which symptoms are recognised, what testing is and isn't useful, and when a consult is worth booking.
Perimenopause is the transition phase leading up to menopause, typically starting in a woman's 40s and lasting four to six years on average. It is driven by progesterone declining first while oestrogen fluctuates unpredictably, producing more than 40 recognised symptoms across sleep, mood, cognition, cycle, body composition, and genitourinary health. In Australia, diagnosis is clinical for women over 45. Blood tests rarely add value.
What perimenopause actually is
Perimenopause is not a single hormonal drop. It is a period of escalating variability. The ovaries are running out of follicles, the brain responds by pushing harder to stimulate them, and the result is a hormonal environment that swings rather than declines in a tidy line. Officially, perimenopause ends one year after the final menstrual period. That endpoint is menopause itself, a single point in time defined retrospectively.
For most Australian women, perimenopause is the symptomatic phase. Menopause is the date on the calendar. Post-menopause is everything after.
The hormonal mechanism, in plain terms
Two hormones drive the experience.
Progesterone declines first. It is made after ovulation, so as ovulatory cycles become less frequent, progesterone exposure drops. Lower progesterone is associated with poorer sleep, increased anxiety, breast tenderness, and heavier bleeding.
Oestrogen fluctuates. Rather than falling steadily, it can spike higher than premenopausal levels and then crash. Those swings drive vasomotor symptoms (hot flushes, night sweats), migraines, mood volatility, and cognitive changes. The Australasian Menopause Society describes perimenopausal symptoms as a mix of oestrogen excess (heavy bleeding, breast tenderness, headaches) and oestrogen deficiency (flushes, sleep disturbance, low mood, joint aches, brain fog, low libido, vaginal dryness).
Testosterone declines gradually across the decade as well, contributing to changes in libido, energy, and muscle.
The clinically important point: if your experience feels inconsistent week to week, that is consistent with what is happening physiologically. It is not in your head.
The symptom spectrum
Over 40 symptoms are now recognised in Australian and international guidelines. Grouped, they look like this.
Hot flushes, night sweats, palpitations, temperature dysregulation.
Insomnia, early waking, fragmented sleep, fatigue that doesn't resolve with rest.
Anxiety (often new onset or intensified), irritability, low mood, tearfulness, reduced stress tolerance, brain fog, word-finding difficulty, reduced short-term memory.
Shorter or longer cycles, heavier or lighter bleeding, skipped periods, mid-cycle spotting, worsening PMS.
Joint aches, muscle stiffness, frozen shoulder, new injuries, slower recovery.
Vaginal dryness, painful sex, recurrent UTIs, urinary urgency, prolapse symptoms.
Central weight gain, insulin resistance, changes in cholesterol, reduced exercise tolerance.
Dry or itchy skin, acne, hair thinning, tinnitus, increased migraines, dry eyes, changes in libido.
Jean Hailes for Women's Health publishes a downloadable symptom checklist that many Australian clinicians use in consultation. Tracking symptoms over four to eight weeks, with rough severity scores, is more diagnostically useful than any single appointment snapshot.
Age range in Australia
The Australian Government's published guidance is consistent with international data. Perimenopause usually begins in a woman's 40s but can start earlier or later. On average it lasts four to six years, with a range of one to ten. The average age of menopause in Australia is 51, with most women reaching it between 45 and 60.
A meaningful minority experience earlier transitions:
- Early menopause is defined as menopause between 40 and 45.
- Premature ovarian insufficiency (POI) is loss of ovarian function before age 40 and affects approximately 1 in 100 women.
For women under 45 with menopausal symptoms, testing matters in a way it does not for women over 45. This is one of the few clear indications for hormone bloods.
Perimenopause vs menopause
The two terms get used interchangeably and they shouldn't.
Perimenopause is the transition. Hormones fluctuate, cycles continue (irregularly), and symptoms are typically at their most volatile. Pregnancy is still possible. Most of the symptom burden women associate with "menopause" is actually perimenopausal.
Menopause is the day twelve consecutive months have passed without a period. It is a single retrospective point.
Post-menopause is everything after that. Vasomotor symptoms often ease over time. Oestrogen stays low, which is why the longer-term health considerations (bone density, cardiovascular risk, genitourinary changes) become more relevant in this phase.
The distinction is clinically important because perimenopause is the volatile, hard-to-test phase, and post-menopause is the sustained low-oestrogen phase where the chronic considerations sit.
Hormone testing in perimenopause, and its limits
This is the area where Australian guidance is clearest and most often misunderstood.
The Australasian Menopause Society's position, consistent with the RACGP and international consensus, is that for women over 45, blood tests are not required to diagnose perimenopause or menopause. FSH and oestradiol fluctuate dramatically across days and weeks during the transition. A single value, normal or abnormal, does not reliably indicate where someone sits. Symptom assessment and cycle history are the diagnostic tools that matter.
Where testing is genuinely useful:
- Women under 40 with menopausal symptoms. FSH testing helps assess for premature ovarian insufficiency. Two elevated FSH results, four to six weeks apart, are required for diagnosis.
- Women aged 40 to 45 with symptoms. FSH can help confirm transition where the clinical picture is ambiguous.
- Ruling out other causes. Thyroid function, iron studies, vitamin D, B12, and HbA1c are often more clinically informative than reproductive hormones, because they identify treatable contributors that mimic perimenopausal symptoms (fatigue, low mood, cognitive change, sleep disruption).
- Baseline metabolic and cardiovascular markers. Lipids, fasting glucose, and blood pressure matter more after the transition. Establishing a baseline in perimenopause is sensible.
The headline: in most cases, the diagnosis is clinical. A test result does not change what good management looks like. Treat the symptoms, not the biochemistry.
When to seek clinical support
There is no symptom threshold a woman has to clear before her experience is worth a consult. About 1 in 2 Australian women report mild to moderate symptoms, and 1 in 4 report symptoms severe enough to disrupt daily life. Both are valid reasons to seek support.
Specific signals worth raising with a clinician:
- Sleep that has been disturbed for more than a few weeks
- New or intensified anxiety, low mood, or panic
- Cognitive changes affecting work
- Heavy or prolonged bleeding, or bleeding between periods
- Painful sex, vaginal dryness, or recurrent UTIs
- Joint pain or musculoskeletal changes without clear cause
- A family history of early menopause, osteoporosis, or cardiovascular disease
Evidence-based management in Australia spans several categories. Menopausal hormone therapy (MHT) is well-studied and remains the most effective option for vasomotor and many other symptoms in appropriately selected women. Non-hormonal medications, cognitive behavioural therapy, vaginal oestrogen for genitourinary symptoms, strength training, nutrition adjustments to support body composition and cardiometabolic health, and sleep interventions all play a role. The right combination depends on the individual, her symptom pattern, her risk profile, and her preferences.
Considering whether perimenopause is part of what you're experiencing? Book a consult with one of our doctors to discuss your symptoms, options, and next steps.
How TWC approaches perimenopause
TWC is a clinician-led multidisciplinary clinic. Perimenopause care sits within our hormonal health protocol, which is built around four working principles.
Diagnosis is symptom-led, with appropriate investigations for women under 45, those with atypical presentations, or those with a family or personal history that warrants closer assessment. We don't run blood panels that won't change management.
Doctors handle diagnosis and prescribing. Dietitians address the metabolic and body composition shifts that perimenopause introduces. Exercise physiologists program for strength, bone density, and cardiovascular health, which become more important during and after the transition. Where relevant, psychology and sleep support are added.
Where the science is settled (for example, the efficacy of MHT for vasomotor symptoms in appropriately selected women), we say so. Where it is mixed or evolving, we say that too. We don't oversell.
Perimenopause is a multi-year phase. The protocol is designed for that timeline, with structured reviews rather than one-off appointments. Members can view protocols, track symptoms, and rebook with their treating doctor through the member portal.
More on the audience landing page at women's health, and on the clinical model at hormonal health.
Frequently asked questions
Usually in a woman's 40s, occasionally earlier. The transition typically lasts four to six years, with a range of one to ten years.
Most commonly, changes to the menstrual cycle (shorter, longer, heavier, or skipped periods), sleep disturbance, new or intensified anxiety, and cognitive changes such as brain fog. Hot flushes can come later than people expect.
Yes. Cycle changes are common but not required. Symptoms can begin before bleeding patterns shift.
If you are over 45, no. Diagnosis is clinical. If you are under 45, FSH testing may be useful. The decision is best made with a clinician based on your full presentation.
Perimenopause is the transition phase, with fluctuating hormones and most of the symptom burden. Menopause is the single point twelve months after your final period.
For most women without specific contraindications, current Australian guidance considers MHT a well-evidenced and effective option for managing symptoms. Risk and benefit profile varies with age, type of therapy, route of administration, and individual health history. This is a conversation to have with a clinician.
The federal government's perimenopause campaign hub, Jean Hailes for Women's Health, and the Australasian Menopause Society are the three most authoritative public resources.
If you'd like to discuss your symptoms with one of our doctors, book a consult. Initial consults are complimentary. If you'd prefer to start lower-friction, you can create a free account to access our member portal and resources.